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Abstract
The gastric lamina propria of mice that have been experimentally infected with the patho-
biont Helicobacter pylori hosts a dense network of myeloid cells that includes BATF3-depen-
dent CD103+ dendritic cells (DCs). We show here that CD103+ DCs are strictly required for
gastric Th1 responses to H. pylori and for H. pylori infection control. A similar dependence of
type 1 immunity on CD103+ DCs is observed in a Mycobacterium bovis BCG infection
model, and in a syngeneic colon cancer model. Strikingly, we find that not only the expan-
sion and/or recruitment of Th1 cells, but also of peripherally induced, neuropilin-negative
regulatory T-cells to sites of infection requires BATF3-dependent DCs. A shared feature of
the examined models is the strongly reduced production of the chemokines and CXCR3
ligands CXCL9, 10 and 11 in BATF3-deficient mice. The results implicate BATF3-depen-
dent DCs in the recruitment of CXCR3+ effector and regulatory T-cells to target tissues and
in their local expansion.
Author summary
In this work, Arnold & Zhang et al report that CD103+ DCs are required for protective
Th1 responses, infection control of mucosal and systemic bacterial pathogens, and anti-
tumor immunity driven by CD4+ Th1 cells and CD8+ T cells. CD103+ DCs further specifi-
cally promote the recruitment of Tbet+ peripherally induced Tregs to sites of infection.
The results implicate CD103+ DCs in the trafficking of CXCR3+ Tbet+ T-cells to sites of
infection and tumorigenesis.
Introduction
Mononuclear phagocytes (MPs) residing in the lamina propria (LP) of the gastrointestinal
(GI) tract comprise populations of resident macrophages that are replenished from Ly6Chi
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blood monocytes, and of dendritic cells (DCs) that originate from a pre-DC-progenitor and
require FLT3L for their development [1, 2]. Three gastrointestinal DC lineages exist in the
steady state; these can be identified based on their surface marker expression, dependence on
transcription and growth factors, and functional specialization. CD103+CD11b- DCs require
the basic leucine zipper transcription factor ATF-like 3 (BATF3) and interferon regulatory fac-
tor 8 (IRF8) for their development [3] and are equipped to cross-present viral, tumor, and self-
antigens; the functional human equivalent of CD103+CD11b- DCs is the CD141hi DC subset
[4]. The development of CD103+CD11b+ DCs depends on granulocyte macrophage colony-
stimulating factor (GM-CSF) [5, 6] as well as the transcription factors Notch-2 [7] and IRF4
[8]. Functionally, IRF4/Notch-2-dependent DCs (likely human equivalent: CD1c+ DCs) have
been implicated in Th17 priming [7, 8]. The third DC subset of the GI tract expresses CD11b
and intermediate levels of CX3CR1, but neither CD103 nor typical macrophage markers such
as F4/80, Ly6C, or CD64. This DC population shares the IRF4/Notch-2 dependence of
CD103+CD11b+ DCs and is responsive to FLT3L in vivo, but its progenitor is controversial
[9–11]. The lymph node counterparts of the described LP DCs are CD11b+ and CD8α+ DCs,
which share the reliance on IRF4/Notch-2 and IRF8/BATF3, respectively.
We have recently conducted a detailed analysis of gastric LP DC populations in the steady
state and during infection with the gastric pathobiont Helicobacter pylori and were able to con-
firm the existence of all three intestinal DC subsets also in this organ, albeit at frequencies that
differed from the intestines [12]. CD11b+CX3CR1
int DCs represented the dominant gastric
DC population and exhibited properties of monocytes/macrophages, i.e. CX3CR1 expression
and the cell-intrinsic dependence on CCR2 signaling, as well as the FLT3L dependence of DCs
[12]. CD11b+CX3CR1
int DCs further showed a previously unknown developmental require-
ment for the inflammasome sensor NLRP3, but not other inflammasome components, a
dependence that applied also to CD11b+CX3CR1
int DCs of other GI tissues and the lung [12].
CD103+CD11b+ DCs were also detected in the stomach, especially upon infection with H.
pylori, and were present at low frequencies that resembled those of the colon rather than those
of the small intestine, where they represent the most dominant DC population by far.
CD103+CD11b- DCs were recruited to the H. pylori-infected stomach along with monocytes,
CX3CR1
hi macrophages and CD11b+ and CD103b+CD11b+ DCs, but, in contrast to the for-
mer populations, appear not to encounter live bacteria in the gastric LP of mice infected with
red fluorescent protein-expressing (RFP+) H. pylori [12].
We and others have reported that DCs that have been exposed to live H. pylori acquire tol-
erogenic properties that drive regulatory T-cell (Treg) rather than T-effector responses [13–
18]. The ability of H. pylori to manipulate DC functionality is particularly evident in an experi-
mental mouse model that entails neonatal infection with H. pylori [19] and mimics the natural
maternal-to-offspring transmission of H. pylori that is characteristic of human populations in
which H. pylori is endemic [20]. In children and in neonatally infected mice, the H. pylori-host
interaction is generally asymptomatic and characterized by the lack of effector T-cell
responses, high level colonization and predominance of Tregs [19, 21]. In contrast, H. pylori-
infected adults, especially those presenting with peptic ulcers, and mice infected as adults,
exhibit a T-cell infiltrate that limits the bacterial burden without clearing H. pylori completely
and is dominated by effector T-cells [19, 21]. The mutualism that is characteristic of the inter-
action between H. pylori and its (neonatally infected) host has been linked to secondary protec-
tive effects against allergic asthma, other forms of allergy, and against inflammatory bowel
diseases in humans [22–24] and in mice [15, 25, 26].
Here, we address the functional contribution of BATF3-dependent CD103+ DCs to H.
pylori-specific immunity and immune tolerance. We examine the role of BATF3-dependent
CD103+ DCs in models of mucosal and systemic bacterial infection and investigate how
BATF3-dependent dendritic cells drive effector and regulatory T-cell responses
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BATF3-dependent DCs contribute to T-cell-driven immunity to bacteria and to anti-tumor
immunity. Our data reveal a non-redundant role of CD103+ DCs in promoting both effector
T-cell and regulatory T-cell responses in bacterially infected tissues, which we attribute to their
ability to recruit and/or locally expand Tbet+ T-cell populations.
Results
CD103+ DCs drive type I immunity to a mucosal bacterial infection
Having observed that CD103+ DCs are recruited to the H. pylori-infected gastric mucosa [12],
we examined their functional contribution to H. pylori-specific immunity in mice that lack the
transcription factor BATF3. The gastric LP of BATF3-/- animals exhibited strongly reduced
numbers of CD103+CD11b- DCs, but was populated by normal complements of CD103+
CD11b+ DCs, D11b+ DCs and macrophages, both in the steady state and during infection (Fig
1A, S1A Fig). Interestingly, BATF3-/- mice had reduced local Th1 responses upon infection as
determined by intracellular cytokine staining for IFN-γ and by quantification of IFN-γ tran-
script levels in the gastric mucosa (Fig 1B and 1C). In contrast, Th17 responses were normal at
one month post infection (p.i.), and even enhanced at 4 months p.i. (Fig 1B and 1C). The
reduced Th1 but not Th17 response in infected BATF3-/- mice was reflected by reduced fre-
quencies of Tbet+, but not of RORγt+ CD4+ T-cells in the infected gastric mucosa (Fig 1D).
The absolute numbers of cytokine-expressing cells per organ, and of Tbet+/RORγt+ CD4+
T-cells per organ, confirmed the trends observed for the frequencies of the respective popula-
tions (S1B and S1C Fig). We further found a lower frequency of actively cycling, Ki67+ T-cells
in the mucosa of BATF3-/- relative to WT mice (Fig 1E, S1D Fig). As a likely consequence of
their inability to generate strong gastric Th1 responses, BATF3-/- mice exhibited a clear defect
in controlling an H. pylori infection (Fig 1F). To rule out that possible differences in the micro-
biota composition of WT and BATF3-/- mice drive the observed differences in H. pylori-spe-
cific T-cell responses, mice of both genotypes were co-housed from birth to the end-point of a
four week H. pylori infection (i.e. for a total of ten weeks). The exact same results as before
were obtained under these experimental conditions: we observed significant hyper-colonisa-
tion of BATF3-/- mice, accompanied by a strong defect in generating Th1 responses (S1E and
S1F Fig). The phenotype of BATF3-/- mice could not be attributed to a defect in Th1 priming,
as the frequencies of IFN-γ-expressing Th1 cells in the draining mesenteric lymph nodes
(MLNs) were normal in BATF3-/- mice (Fig 1G). The phenotype of BATF3-/- mice further
could also not be linked to differences present already at steady state, as Th1 populations were
indistinguishable in the absence of an H. pylori infection (S1F Fig). To rule out that the failure
of BATF3-/- mice to recruit T-cells to, or activate them in the infected gastric mucosa was T-
cell intrinsic, we adoptively transferred CD45.1+ cells that we had isolated from the spleens of
H. pylori-infected donors into WT or BATF3-/- recipients that had been infected for four
weeks with H. pylori. Although very few adoptively transferred cells could be re-isolated from
the recipients after five days, their recruitment to the gastric mucosa appeared to be infection-
and also somewhat BATF3-dependent (Fig 1H).
Tbet-positive T-cells express the chemokine receptor CXCR3, which allows the cells to
migrate along gradients of the CXCR3 ligands CXCL9, CXCL10 and CXCL11 to their target
tissues [27, 28]. We therefore examined the expression of these chemokines in H. pylori-
infected gastric tissue. Interestingly, the gastric mucosa of BATF3-/- mice exhibited lower
expression levels of CXCL9, CXCL10 and CXCL11 than that of their WT counterparts (Fig
1I). To identify the DC population(s) that could serve as major sources of these chemokines in
the gastric lamina propria, and to examine the relative contribution of the three chemokines,
we flow cytometrically sorted CD103+, CD11b+ and CD103+CD11b+ DCs from the lamina
BATF3-dependent dendritic cells drive effector and regulatory T-cell responses
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1007866 June 12, 2019 3 / 23
Fig 1. BATF3-dependent DCs are required for local Th1 responses and bacterial infection control. (A-D) BATF3-/- and WT mice were infected with H. pylori and
their gastric LP leukocytes were analyzed by FACS at one or four months p.i. (A) Absolute counts of CD103+ CD11b- DCs in the gastric LP of naïve and infected WT
and BATF3-/- mice. Representative FACS plots are shown alongside summary plots. (B) Frequencies of IFN-γ+ and IL-17+ CD4+ T-cells of the mice shown in A. The
summary plot shows a representative time course of three independently conducted experiments. (C) Expression of IFN-γ and IL-17 in the gastric mucosa of WT and
BATF3-/- mice at four months p.i.; results are pooled from two independent experiments. (D) RORγt and Tbet expression of LP CD4+ T-cells of the mice shown in A at
four months p.i. (E) Mice of the two genotypes were infected as described above, and subjected to Ki67 staining of their LP T-cells. Results are from one experiment. (F)
BATF3-dependent dendritic cells drive effector and regulatory T-cell responses
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propria of infected and uninfected WT mice and subjected pools of 30–100 highly pure cells to
qRT-PCR analysis. Whereas CXCL11 transcripts were extremely rare in all three populations,
the other two chemokines were clearly detectable in all three DC subsets; exposure to H. pylori
resulted in enhanced expression of CXCL10, whereas CXCL9 was expressed constitutively
(S1G Fig). The combined results suggest that CD103+ DCs have a non-redundant role in pro-
viding the local signals driving Th1 recruitment and expansion and bacterial infection control
in this mucosal infection model; however, this contribution cannot be attributed to CD103+
DCs being the exclusive source of these chemokines in the gastric lamina propria.
CD103+ DCs promote Th1 responses to systemic infection with M. bovis
BCG
To assess whether BATF3-dependent DCs also contribute to the control of systemic bacterial
infection, we infected WT and BATF3-deficient mice with M. bovis BCG. At three weeks p.i.,
spleens were isolated for the analysis of bacterial growth and of BCG-specific immune
responses. The spleens and livers of BATF3-/- mice were lighter than WT spleens (Fig 2A),
exhibited reduced Th1 responses as determined by intracellular cytokine staining for IFN-γ
and TNF-α (Fig 2B and 2C), and were colonized at higher levels than WT spleens (Fig 2D).
Similar observations with respect to colonization and the magnitude of BCG-specific Th1
responses were made in the liver, which in BATF3-/- mice was colonized at higher levels than
in WT mice (Fig 2E) and which, just like the spleen, exhibited reduced Th1 responses (Fig 2F
and 2G). Th17 responses were not elevated due to BCG infection of the liver, and did not differ
between the two strains (S2A Fig). We also observed clear BATF3-dependent differences in
infection-induced cytokine expression in the liver. The Th1 cytokines IFN-γ, TNF-α, GM-CSF
and IL-2 were all produced at higher levels in WT relative to BATF3-/- mice (Fig 2H and 2I). A
similar pattern was observed for the Th1-specific transcription factor Tbet and the Th1-polar-
izing cytokine IL-12 (Fig 2J). In contrast, the expression of cytokines and transcription factors
associated with Th2-, Th17-, and regulatory T-cell responses was similar in the livers of
infected WT and BATF3-/- mice (S2B Fig). Interestingly, and as observed after infection of
mice with H. pylori, the expression of the chemokines CXCL9 and CXCL10 was strongly
reduced in BCG-infected BATF3-deficient compared to WT mice (Fig 2K), whereas CXCL11
expression was unaffected by the BCG infection or the mouse genotype (S2B Fig). The com-
bined results suggest that the (Th1-dependent) control of mucosal as well as systemic bacterial
infections requires BATF3-dependent DCs.
CD103+ DCs support anti-tumor immunity by promoting Th1 and CD8+
T-cell responses
To investigate the role of BATF3-dependent DCs in a model of T-cell driven anti-tumor
immunity, we took advantage of the highly immunogenic MC38 colon cancer xenograft
model, which is known to be strictly controlled by both CD4+ and CD8+ T-cells. We found
that BATF3 deficiency facilitated MC38 tumor growth (Fig 3A and 3B). MC38 tumors were
infiltrated by a variety of immune cells, of which CD103+ DCs constituted a small but robust
population, both in terms of their frequencies and absolute numbers (Fig 3C, S3A Fig). As
expected, BATF3-dependent CD103+CD11b- DCs were absent in tumors of BATF3-/- mice,
H. pylori colonization of the mice shown in A-D. (G) IFN-γ expression of CD4+ T-cells in the MLNs of WT and BATF3-/- mice infected with H. pylori for 1 and/or 4
months as shown in A. Results are representative of two independent experiments. (H) Absolute numbers of adoptively transferred CD45.1+ CD4+ T-cells recovered
from the gastric LP of recipients of the indicated genotypes five days post adoptive transfer. Naïve recipients of T-cells are shown as controls alongside H. pylori-infected
recipients. (I) Expression of CXCL9, 10 and 11 in the gastric mucosa of WT and BATF3-/- mice four months p.i.; results are pooled from two independent experiments.
https://doi.org/10.1371/journal.ppat.1007866.g001
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Fig 2. BATF3-dependent DCs are required for systemic bacterial infection control. (A-K) BATF3-/- and WT mice were infected with M. bovis BCG for three weeks
and their spleen weights (A), splenic frequencies of IFN-γ+ CD4+ T-cells (B, summary plot and representative FACS plots), splenic frequencies of TNF-α+ CD4+ T-cells
BATF3-dependent dendritic cells drive effector and regulatory T-cell responses
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whereas CD103+CD11b+ DCs infiltrated the tumors of BATF3-proficient and -deficient mice
at similar frequencies and absolute numbers (Fig 3C, S3A Fig). Interestingly, the infiltration of
CD4+ and CD8+ T-cells, but not of NK cells, into the tumor mass depended strongly on
BATF3-dependent DCs (Fig 3D, S3B and S3C Fig). The residual population of tumor-infiltrat-
ing CD4+ T-cells exhibited reduced expression of the early activation marker CD69 (Fig 3E).
Th1 cells, identified by their expression of IFN-γ and TNF-α, were reduced both in frequencies
and numbers in the tumor mass of BATF3-/- mice (Fig 3F, S3D Fig). CD8+ T-cells in tumors
from WT and BATF3-deficient mice did not differ in terms of their CD69 expression (Fig 3G);
there were however much fewer cytokine-expressing CD8+ T-cells detectable in tumors of
BATF3-/- relative to WT mice, as assessed both upon re-stimulation with PMA/ionomycin, as
well as with MC38 tumor antigen-derived peptide (Fig 3H and 3I, S3E Fig). CD69 expression
on tumor-associated NK cells was similar in WT and BATF3-deficient mice (S3F Fig). Inter-
estingly, the cytotoxic activity of CD8+ T-cells, as judged by expression of their degranulation
marker CD107 and their granzyme B expression, was strongly reduced in the absence of
BATF3-dependent DCs (Fig 3J, S3G Fig). Intratumoral frequencies of multifunctional CD8+
T-cells expressing both cytokines and the degranulation marker CD107 were particularly
strongly reduced in BATF3-/- mice (Fig 3K). These results were confirmed by qRT-PCR analy-
sis of IFN-γ and TNF-α expression performed on tumor tissues (Fig 3L, S3H Fig). Interest-
ingly, the defect of BATF3-/- mice in generating anti-tumor immune responses could not be
attributed to a priming defect, as frequencies of cytokine-producing CD8+ T-cells were higher
rather than lower in the draining inguinal lymph nodes of tumor-bearing BATF3-/- mice rela-
tive to WT controls (Fig 3M). Rather, tumors in BATF3-/- mice lacked expression of the T-cell
recruiting chemokines CXCL9, CXCL10, and CXCL11 (Fig 3N), which could be attributed to
differential CXCL9 expression in the DC compartment (Fig 3O, S3I Fig). In summary, in the
absence of this DC subset, T-cell priming appears to occur normally but activated T-cells fail
to migrate to the tumor site due to lack of the appropriate chemokine gradient.
CD103+ DCs promote the recruitment of Tbet+ RORγt+ peripherally
induced Tregs to sites of infection
We have shown previously that BATF3-dependent DCs are required for immune tolerance to
H. pylori and for the immunomodulatory effects of H. pylori in models of allergen-induced
asthma [29], which in turn are driven by H. pylori-induced, highly suppressive regulatory T-
cells (Tregs) [15, 25, 30]. To address whether BATF3-dependent DCs are required for the H.
pylori-dependent differentiation and recruitment of Tregs, we infected WT and BATF3-/- mice
with H. pylori for one month (as before, Fig 1) and analyzed the gastric LP Treg compartment
by flow cytometry. Although we found the frequencies of CD4+ Foxp3+ Tregs to be compara-
ble in the gastric LP of WT and BATF3-/- mice, both in the steady state and upon infection
(Fig 4A), the composition of the Treg compartment differed substantially as a result of BATF3
deficiency. We observed a shift from thymus-derived, neuropilin-positive tTregs to peripher-
ally induced, neuropilin-negative pTregs in the WT gastric LP as a consequence of H. pylori
infection (Fig 4B and 4C); pTregs were largely Tbet- and RORγt-positive (Fig 4D and 4E). The
recruitment of pTregs was substantially reduced in the gastric LP of BATF3-/- mice and this
(C), and splenic BCG colonization (D) are shown. Restimulation of T-cells was performed with BCG-specific purified protein derivate (PPD). Pooled data from two
independent experiments are shown throughout with the exception of panel D, which is from three pooled experiments. (E-K) Liver colonization of mice infected with
BCG as described above (E), Th1 responses (F,G) and gene expression of transcripts associated with Th1 polarization (H-J) and with chemokine production (K), as
assessed by qRT-PCR and normalized to Hprt. Data in E and H-K are pooled from two studies; data in F and G are from one study and representative of two
independent ones.
https://doi.org/10.1371/journal.ppat.1007866.g002
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observation was particularly evident for Tbet+ RORγt+ pTregs (Fig 4B–4E); the changes in
Treg subset frequencies were mirrored by the absolute counts of the same populations (suppl
Fig 4A–4E). Other Treg or general T-cell activation markers (i.e. TIGIT, CD44, Tim3) did not
vary measurably due to BATF3 deficiency (suppl Fig 4F–4H). The defective pTreg recruitment
to the site of infection in BATF3-/- mice could not be attributed to a differential composition
of the microbiota of WT and BATF3-/- mice, as co-housing the mice from birth until the study
endpoint produced the same results, i.e. a selective defect in the recruitment of pTregs express-
ing Tbet and RORγt to the site of infection (suppl Fig 4I–4M). The combined results suggest
that BATF3-/- mice exhibit a specific defect in the recruitment of pTregs to target tissues.
BATF3-/- mice fail to induce CXCR3 expression in peripherally induced
Tregs
We next addressed whether the differences in pTreg recruitment to the site of infection in WT
and BATF3-/- mice were attributable to differential priming of Tregs in the MLNs upon H.
pylori infection. Interestingly, we found (p)Treg populations to be elevated rather than reduced
in the MLNs of BATF3-/- mice, as assessed in terms of their frequencies (Fig 5A–5C) and abso-
lute numbers (suppl Fig 5A–5C). This effect was also observed if animals were co-housed
(suppl Fig 5D–5F). Our analyses thus corroborate earlier reports of an over-representation of
Foxp3+ Tregs in the LNs of BATF3-deficient mice [31]. As we could not attribute the defect of
pTreg recruitment to the infected stomach to a generalized deficiency in the pTreg compart-
ment, we focused on the CXCR3 expression of MLN Tregs as an indicator of their ability to
traffic to infected tissues along chemokine gradients. Most CXCR3-expressing Tregs in the
MLNs of infected mice were neuropilin-negative pTregs (Fig 5D) that were also positive for
RORγt. The frequency of this population in the MLNs increased strongly upon infection, and
this was highly dependent on BATF3 (Fig 5E). The same differential expression of CXCR3 was
observed in Foxp3- CD4+ effector T-cells of the same MLN preparations (Fig 5F). To examine
using an independent, complementary approach whether neuropilin-negative pTregs are
indeed peripherally and microbially induced, we subjected mice to a four week course of anti-
biotic eradication using a combination of the four antibiotics ampicillin, vancomycin, neomy-
cin and metronidazole, administered via the drinking water. Eradicated mice exhibited
significantly reduced frequencies of neuropilin-negative pTregs, and especially of neuropilin-
negative RORγt-positive pTregs in the MLNs (Fig 5G–5I), and this reduction in pTregs was
Fig 3. BATF3-dependent DCs are required for CD4+ and CD8+ T-cell recruitment to the tumor microenvironment and for tumor
control. (A-O) WT and BATF3-/- mice were subcutaneously injected in both flanks with 5×105 MC38 cells. Tumors were analyzed after 15 days
with respect to tumor weight (A), volume (B), leukocyte infiltration (C-K, M, and O) and mRNA expression profile (L and N). (A,B) Tumor
weights and volumes as determined at the study endpoint. Data are pooled from two independent studies. (C,D) Frequencies of CD103+
CD11b+ and CD103+ CD11b- DCs (C) and of CD4+ and CD8+ T-cells (D) among all tumor-infiltrating leukocytes. One representative study of
two is shown. (E) Frequencies of CD69+ CD4+ T-cells. Data are from the study shown in C and D, and presented along with representative
FACS plots. (F) Frequencies of IFN-γ+ and TNF-α+ CD4+ T-cells among all CD45+ T-cells, as assessed upon re-stimulation with PMA/
ionomycin. Data are from the study shown in C and D, and representative of two independent ones. (G) Frequencies of CD69+ CD8+ T-cells.
Data are from the study shown in C and D, and presented along with representative FACS plots. (H) Frequencies of IFN-γ+ and TNF-α+ CD8+
T-cells among all CD45+ T-cells, as assessed upon re-stimulation with PMA/ionomycin. Data are from the study shown in C and D, and
representative of two independent ones. (I) Frequencies of IFN-γ+ CD8+ T-cells among all CD45+ T-cells, as assessed upon re-stimulation with
MC38 tumor-specific peptide. (J) Frequencies of CD107+ CD8+ T-cells. Data are from the study shown in C and D, and presented along with
representative FACS plots. (K) Frequencies of CD8+ T-cells co-expressing CD107 and IFN-γ. Data are from the study shown in C and D, and
presented along with representative FACS plots. (L) IFN-γ expression as assessed by qRT-PCR of tumor tissue, of the studies shown in A and B.
(M) Frequencies of IFN-γ+ CD8+ T-cells in the inguinal LNs of tumor-bearing (+MC38) relative to naïve mice, as assessed upon re-stimulation
with PMA/ionomycin. Data are from the study shown in C and D, and representative of two independent ones. (N) Expression of the indicated
T-cell-attracting chemokines, as assessed by qRT-PCR of tumor tissue, of the studies shown in A and B. Horizontal lines indicate medians
throughout; statistical analyses were done using the Mann-Whitney test. �p<0.05; ��p<0.01; ���p<0.0005. (O) Frequencies of CXCL9+ DCs
among all CD11c+ cells. Data are from the study shown in C and D; see S3I Fig for the gating strategy and representative FACS plots.
https://doi.org/10.1371/journal.ppat.1007866.g003
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observed irrespective of BATF3 proficiency. The combined results attribute the pTreg recruit-
ment defect of BATF3-/- mice to their inability to induce the expression of the chemokine
receptor CXCR3 on pTregs during their priming in lymph nodes on the one hand, and their
inability to generate gradients of the chemokine ligands of this receptor, CXCL9, 10 and 11, in
infected tissues on the other.
The neutralization of CXCR3 phenocopies some but not all consequences
of BATF3 deficiency
The dual defect of BATF3-/- mice in priming Tregs and effector T-cells that express CXCR3
and in generating chemokine gradients for T-cell recruitment to infected tissues provided a
strong rationale for blocking the interaction of CXCR3 with its ligands with a neutralizing
antibody in the MC38 tumor model and during H. pylori infection. In the MC38 tumor
model, twice weekly intraperitoneal administration of a CXCR3-neutralizing antibody led to
Fig 4. BATF3-dependent DCs are required for peripherally induced Treg recruitment to the LP of the GI tract. (A-E) WT and BATF3-/- mice
were infected with H. pylori and the gastric LP Treg compartment was analyzed one month p.i. by FACS and compared to that of naïve controls of
both genotypes. (A) Frequencies of LP Foxp3+ regulatory CD4+ T-cells. Data are pooled from two independent experiments, and representative of
four experiments. (B,C) Frequencies of neuropilin-1 (Nrp-1)-positive thymus-derived and Nrp-1-negative peripherally-induced Tregs (tTregs,
pTregs) among all CD4+ Foxp3+ LP Tregs. Data are from the studies shown in A. (D,E) Frequencies of Tbet+ (D) and Tbet+RORγt+ (E) pTregs
among all CD4+ Foxp3+ LP Tregs. Summary and representative FACS plots are shown. Horizontal lines indicate medians throughout; statistical
analyses were done using one-way ANOVA followed by Holm-Sidak’s multiple comparisons correction. �p<0.05; ��p<0.01; ���p<0.0005;
����p<0.0001.
https://doi.org/10.1371/journal.ppat.1007866.g004
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larger and heavier tumors at the study endpoint (Fig 6A and 6B), a strongly reduced infiltra-
tion of CD4+ and of CD8+ T-cells into the tumor mass (Fig 6C) and reduced IFN-γ and TNF-
α production by the residual populations of both CD4+ and CD8+ T-cells (Fig 6D–6F).
Fig 5. BATF3-dependent DCs are required for the induction of CXCR3 expression on peripherally induced Tregs in the MLNs. (A-F) WT and BATF3-/- mice
were infected with H. pylori and the MLN Treg compartment was analyzed one month p.i. by FACS and compared to that of naïve controls of both genotypes. MLN
frequencies of all FoxP3+ Tregs (A), tTregs (B) and pTregs (C) are shown, along with the frequencies of CXCR3+ pTregs and their representative FACS plots (D,E) and
of CXCR3+ CD4+ Foxp3- T-cells (F). (G-I) WT and BATF3-/- mice were subjected to a four week-long course of antibiotic eradication therapy prior to the analysis of
their MLN Treg compartment by FACS. MLN frequencies of Foxp3+ Nrp- pTregs (G), and RORγt+ pTregs (H) are shown relative to untreated controls, and alongside
representative FACS plots in I. Horizontal lines indicate medians throughout and p-values were calculated using one-way ANOVA followed by Holm-Sidak’s multiple
comparisons correction. �p<0.05; ��p<0.01; ���p<0.0005; ����p<0.0001.
https://doi.org/10.1371/journal.ppat.1007866.g005
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Similarly, CXCR3 neutralization during a four week time course of H. pylori infection strongly
reduced the infiltration of all CD4+ T-cells and of Th1 cells into the infected gastric mucosa
Fig 6. CXCR3 signaling is required for type I immunity and tumor control. (A-F) WT mice were subcutaneously injected in both flanks with 5×105 MC38 cells and
received twice weekly doses of CXCR3-neutralizing or isotype control antibody from the day of tumor cell injection. Tumors were analyzed after 15 days with respect
to tumor weight, volume and T-cell infiltration. (A,B) Tumor weights and volumes as determined at the study endpoint. (C) Frequencies of CD4+ and CD8+ T-cells
among all tumor-infiltrating leukocytes. (D-F) Frequencies of IFN-γ+ and TNF-α+ CD4+ and CD8+ T-cells, as assessed upon re-stimulation with PMA/ionomycin (D,
E) or upon re-stimulation with MC38 peptide (F). (G-L) WT mice were infected for four weeks with H. pylori and received twice weekly doses of CXCR3-neutralizing
or isotype control antibody starting from the day of infection. (G) Absolute counts of CD4+ T-cells per stomach. (H,I) Absolute counts of IFN-γ+ and IL-17+ CD4+ T-
cells per stomach. (J,K) Absolute counts of Foxp3+ Tregs and of Foxp3+ Nrp- pTregs per stomach. (L) H. pylori colonization of the mice shown in G-K. Data in A-F
are from one experiment and data from G-L are pooled from two independent ones. Horizontal lines indicate medians throughout and p-values were calculated using
by Mann-Whitney test (A-F) and one-way ANOVA followed by Holm-Sidak’s multiple comparisons correction (G-L).
https://doi.org/10.1371/journal.ppat.1007866.g006
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(Fig 6G and 6H). Trends toward lower Th17 cells and Foxp3+ Tregs, as well as lower RORgt+
pTregs were observed in CXCR3 antibody-treated mice (Fig 6I–6K). H. pylori colonization lev-
els did not differ significantly as a consequence of CXCR3 neutralization (Fig 6L). The com-
bined results lend further support to the idea that the CXCL9,10/CXCR3 signaling axis is
required for Th1 and Treg trafficking to target tissues.
CD103+ DCs promote the systemic immunomodulatory effects of H. pylori
infection
As BATF3-dependent DCs are required for immune tolerance to H. pylori and for the immu-
nomodulatory effects of H. pylori in models of allergen-induced airway inflammation [29], we
examined the frequencies of pulmonary Tregs in WT and BATF3-/- mice that were infected
with H. pylori. As only mice that have been experimentally infected in the neonatal period ben-
efit from reduced allergy symptoms whereas mice infected as adults do not [25], we compared
pulmonary Treg populations of mice infected neonatally and as adults. We observed a modest
but reproducible increase in the frequencies of neuropilin-negative pTregs expressing Tbet
and RORγt as a consequence of neonatal, but not adult infection in WT mice; this increase
was dependent on BATF3 (Fig 7A–7D). Tbet and RORγt were co-expressed in pulmonary
pTregs (Fig 7C). Overall, the changes in Treg subsets in the pulmonary compartment are con-
sistent with our previous observation of lack of immune tolerance to airway inflammation in
BATF3-/- mice and implicate microbially induced pTregs originating in the GI tract in
immune regulation at distant sites.
Discussion
We show here that BATF3-dependent DCs are absolutely required for the Th1-driven control
of a mucosal and a systemic bacterial pathogen, H. pylori and M. bovis BCG. Our data are in
line with previous evidence for a critical role of BATF3-dependent CD103+ DCs in the activa-
tion and expansion of Th1 cells in murine models of Leishmania major infection [32] and in
immune protection against the newly identified protist Tritrichomonas musculis that colonizes
the murine intestine and triggers strongly Th1-polarized T-cell responses [33]. Our data sup-
port a model where BATF3-dependent DCs are dispensable for T-cell priming -as we find Th1
cell frequencies in the MLNs to be relatively normal- but indispensible for Th1 cell recruitment
to, and expansion in the target tissue. BATF3-dependent CD103+ DCs of the GI tract are better
known for their potency at driving CD8+ T cell immunity [3, 34, 35] and for their role in prim-
ing Treg differentiation through the production of retinoic acid [36, 37]. Our data, as well as
the results from the Leishmania and Tritrichomonas musculis studies [32], further attribute an
essential function in promoting local Th1 responses to this versatile DC subset in the GI tract.
In addition to their role in promoting type I immunity to bacterial infections, CD103+ DCs
are indispensable for tumor control. CD103+ DCs are found at low but consistent frequencies
in the tumor microenvironment of highly immunogenic tumor cell lines such as the MC38
colon carcinoma cell line used here. Their specific loss leads to larger tumors that exhibit
reduced infiltration of both CD4+ and CD8+ T-cells, despite the fact that T-cell priming
appears to be normal in tumor-bearing BATF3-/- mice. Our results are consistent with previ-
ous reports that have linked functional CD103+ DCs to therapy success in models of cancer
immunotherapy with anti-CD137 and anti-PD-1 antibodies [38], of adoptive T-cell transfer
therapy [39] and even of chemotherapy [40]. In these experimental models, CD103+ DCs were
shown to be required for cross-priming of tumor antigens [38] and for T-cell trafficking of
adoptively transferred therapeutic T-cells [39], respectively. The success of chemotherapy was
enhanced by anti-TIM3 antibodies that presumably targeted the CD103+ DC compartment in
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this setting [40]. In several of these therapeutic scenarios, intratumoral CD103+ DCs contrib-
uted to tumor immunity through production of T-cell recruiting chemokines such as CXCL9
and CXCL10 [39, 40]. We show here that BATF3-dependent CD103+ DCs are not only
Fig 7. BATF3-dependent DCs promote the recruitment of Tbet+ RORγt+ pTregs to the lungs of neonatally infected mice. (A-D) BATF3-/- and WT mice were
infected with H. pylori either as neonates (iN) or as adults (iA), and the lungs were analyzed by FACS 6 (iN) and 4 (iA) weeks p.i. (A) Representative FACS plots of
neuropilin vs. Tbet expression. (B) Representative FACS plots of neuropilin vs. RORγt expression. (C) Representative FACS plots of Tbet vs. RORγt expression. (D)
Frequencies of the pTreg subsets shown in A-C among all pulmonary Foxp3+ Tregs. In all graphs, horizontal lines indicate medians and p-values were calculated using
ANOVA. �p<0.05; ��p<0.01; ���p<0.0005. Data in A-D are pooled from two experiments, and are representative of three independently conducted ones.
https://doi.org/10.1371/journal.ppat.1007866.g007
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required for therapy success as reported previously, but also for the spontaneous control of
tumor growth. Our data point to a dual role of CD103+ DCs in T-cell trafficking: in the
absence of this DC subset, chemokine gradients that in WT mice would allow T-cells to
migrate to infected tissues or tumors are not established, and the expression of the chemokine
receptor for CXCL9 and CXCL10, CXCR3, is not induced during priming in the draining
LNs.
To our surprise, we found that CD103+ DCs are not only required for effector T-cell
recruitment and function in tumor and infected tissues, but also for pTreg recruitment to sites
of infection. The gastric LP Treg compartment in naive mice consists of roughly equally sized
populations of neuropilin-positive thymus-derived tTregs and peripherally induced pTregs.
This distribution is different from that found in the intestines, where pTregs comprise ~80%
of the total Treg pool [41]. Upon infection with H. pylori, the pTreg compartment expands at
the expense of tTregs, and a significant fraction of the gastric LP pTreg population that is gen-
erated during infection expresses Tbet and RORγt. The increase in gastric LP pTreg frequen-
cies upon infection can largely be attributed to an increase in these Tbet+ RORγt+ pTregs, and
is highly dependent on BATF3. Previous reports have shown that the differentiation of pTregs
in the periphery requires microbial signals (germ-free mice for example lack this population)
as well as TGF-β and retinoic acid [42, 43]. CD103+ DCs are a well-known source of both fac-
tors in the gut LP [36, 44]; activation of the TGF-β signaling pathway in naïve T-cells leads to
the binding of SMAD2 and SMAD3 to a response element, termed conserved non-coding
sequence 1 (CNS1), which is part of a Foxp3 intronic enhancer and is known to regulate Foxp3
expression in pTregs [45]. CNS1 also contains a binding site for the retinoic acid receptor [46];
TGF-β and retinoic acid signaling are believed to synergize with microbial antigenic stimula-
tion via the T-cell receptor and the chromatin-modifying activities of bacterial fermentation
products, such as short chain fatty acids, to promote RORγt+ pTreg differentiation [41]. Our
results indicate that CD103+ DCs have an additional, non-redundant function during the
recruitment of pTregs to sites of infection, as we find that the induction of CXCR3 expression
in pTregs during their priming in the LNs is highly dependent on this DC subset. The lack of
CXCR3 expression, in conjunction with an impaired CXCL9/10 chemokine gradient, compro-
mises the ability of pTregs to traffic to infected tissues. Our data are in line with two recently
proposed concepts. On the one hand, there is now solid evidence for the idea that Th1-polar-
ized settings of viral or bacterial infection promote Tregs that, like their effector T-cell counter-
parts, express Tbet and CXCR3 [47]; indeed, we find that H. pylori induces concomitant Th1
and Tbet+ pTreg responses, and that both depend on BATF3. On the other hand, co-expres-
sion of Tbet with Foxp3 is essential for Treg cells to control Th1 responses, as the depletion of
Tbet-expressing Treg cells -but not of Tbet expression in Treg cells-results in severe Th1 auto-
immunity [48].
Our observations together with the published data may explain the defect of BATF3-/- mice
in various models of peripheral and central immune tolerance. We have reported previously
that BATF3-/- mice, in contrast to their WT counterparts, are not protected against allergic air-
way inflammation upon H. pylori infection [29]; others have observed similar defects of
BATF3-/- mice in models of pulmonary tolerization by inhaled antigen [49], of graft-versus-
host disease after allogeneic hematopoietic stem cell transplantation [50], and of presentation
of Aire-induced self-antigens to developing thymocytes [51].
In summary, our results suggest that CD103+ DCs promote T-cell trafficking through two
complementary mechanisms, i.e. by inducing the expression of CXCR3 on effector and regula-
tory T-cells during priming in the draining lymph nodes and by establishing a gradient of the
CXCR3 ligands CXCL9 and CXCL10 in infected tissues.
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Materials and methods
Mice
C57BL/6 and BATF3-/- mice were purchased from the Jackson laboratory. CD45.1 congenic
mice were obtained from a local repository. All strains were bred and maintained under spe-
cific pathogen-free conditions in accredited animal facilities at the University of Zurich.
H. pylori infection
The H. pylori strain used in this study, PMSS1, is a clinical isolate of a patient with duodenal
ulcer and the parental strain of the mouse-derivative Sydney strain 1 (SS1) [19] and was origi-
nally obtained from Adrian Lee, Univ. of New South Wales, Sydney, Australia. H. pylori was
grown on horse blood agar plates and in liquid culture as described previously [19]. Cultures
were routinely assessed by light microscopy for contamination, morphology, and motility.
Mice were infected orally on two consecutive days with 108 CFU H. pylori PMSS1 at 7 days or
6 weeks of age and analyzed at 1 or 4 months p.i. unless specified otherwise. For adoptive
transfer experiments, 1 Mio splenic immunomagnetically isolated (naïve CD4 T-cell isolation
kit, MagCellect, R&D Systems) naïve CD4+ T-cells from infected murine donors were trans-
ferred into recipient mice that had been infected for four weeks with H. pylori.
M. bovis BCG infection
Mice were infected intraperitoneally with 5x106 CFU M. Bovis BCG 1721, a derivative of M.
bovis BCG Pasteur. Mice were euthanized on day 21 p.i., and spleens and livers were harvested
and weighed. To assess BCG colonization, spleens and livers were individually homogenized
and serial dilutions were plated on antibiotic-free Middlebrook Agar 7H10 plates (BD Biosci-
ences), supplemented with Middlebrook OADC enrichment (BD Biosciences). Splenocytes
and liver leukocyte preparations were re-stimulated in vitro with 5 μg/ml BCG-specific puri-
fied protein derivate (PPD) from Statens Serum Institut (Copenhagen, Denmark) and subse-
quently analyzed by flow cytometry for production of cytokines.
MC38 tumor model
The murine colorectal cancer cell line MC38 is derived from C57BL/6 mice and was gener-
ously provided by Prof. Lubor Borsig (University of Zurich, Zurich, Switzerland). Cells were
maintained in Dulbecco’s modified Eagle’s medium supplemented with 100U/ml penicillin/
streptomycin and 10% heat-inactivated fetal calf serum (FCS) at 37˚C in 5% CO2. 5×105 MC38
cells were subcutaneously injected in both flanks of C57BL/6 WT or BATF3-/- mice, and the
tumors were analyzed after 15 days for tumor weight, volume, leukocyte infiltration and RNA
expression profile. The CXCR3 blocking antibody (clone: CXCR3-173) was purchased from
BioXCell (West Lebanon, NH) and administered twice weekly intraperitoneally (first dose:
500 μg/dose, all subsequent doses: 250 μg) starting on the day of tumor cell injection or H.
pylori infection.
Depletion of intestinal commensals by antibiotic treatment
For the depletion of gut commensal microbiota, animals were given ampicillin (1 g l−1; Sigma),
vancomycin (500 mg l−1; Applichem), neomycin sulphate (N; 1 g l−1; Applichem), and metro-
nidazole (1 g l−1; Sigma) in their drinking water for four weeks as described previously [52].
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Leukocyte isolation
For LP leukocyte isolation, gastrointestinal tissues were opened longitudinally, washed and cut
into pieces. Pieces were incubated in Hanks’ balanced salt solution with 10% FCS and 5 mM
EDTA at 37˚C to remove epithelial cells. Tissue was digested at 37 ˚C for 50 min in a shaking
incubator with 15 mM HEPES, 500 U/ml of type IV collagenase (Sigma-Aldrich) and 0.05 mg
ml−1 DNase I in supplemented RPMI-1640 medium. Cells were then layered onto a 40/80%
Percoll gradient, centrifuged, and the interface was washed in PBS with 0.5% BSA. Lymph node
cell suspensions were prepared by digesting the LNs in 500 U/ml of type-IV collagenase in
RPMI-1640 for 15 min followed by pushing through a cell strainer using a syringe plunger.
Splenocytes suspensions were prepared by pushing the spleens through a cell strainer followed
by ACK red blood cell lysis. Lung cell suspensions were prepared by perfusing the lung with
PBS, followed by pushing the lung through a cell strainer. Similarily, 80–100 mg tumor slices
were cut into pieces and digested in type IV collagenase and 0.05 mg/ml DNase I at 37 ˚C for 50
min under agitation in supplemented RPMI-1640 medium, followed by pushing through a cell
strainer. Liver cell suspensions were prepared by chopping the liver into pieces and digestion at
37 ˚C for 45 min in a shaking incubator with 500 U/ml of type IV collagenase (Sigma-Aldrich)
and 0.05 mg ml−1 DNase I in supplemented RPMI-1640 medium. Cells were layered onto a 40/
75% Percoll gradient, centrifuged and the interface was washed in PBS with 0.5% BSA.
Flow cytometry, T-cell re-stimulation and cell counting
Cells were stained with a fixable viability dye and a combination of the following antibodies:
anti-mouse CD45 (clone 30-F11), CD45.1 (A20), CD11c (N418), MHCII (M5/114.15.2), F4/80
(BM8), CD103 (M2E7), CD11b (M1/70), CD3e (145-2C11), CD4 (RM4-5), CD8 (53–6.7),
NK1.1 (PK136), TCRβ (H57-597), CD44 (1M7), CD69 (H1.2F3), Neuropilin-1 (3E12), TIGIT
(1G9), CXCR3 (CXCR3-173) and CXCL9 (MIG-2F5.5), Ki67 (16A8), CD45.1 (A20), or an IgG
isotype control (all from BioLegend), as well as TIM3 (FAB1529P, R&D). Fc block (anti-
CD16/CD32, Affymetrix) was included to minimize nonspecific antibody binding. For intra-
cellular cytokine staining, the cells were incubated at 37˚C for 3.5 h in complete IMDM
medium containing 0.1 μM phorbol 12-myristate 13-acetate and 1 μM ionomycin with
1:1,000 brefeldin A (eBioscience) and GolgiStop solutions (BD Biosciences) at 37 ˚C in a
humidified incubator with 5% CO2. Where indicated, CD107a (LAMP-1, Biolegend) was
included during the T-cell re-stimulation. MC38 tumor-cell suspensions were re-stimulated with
H-2Kb-restricted MC38 peptide (KSPWFTTL) at 37˚C for 3.5 h in complete IMDM medium
containing brefeldin A and GolgiStop solutions. Following surface staining, cells were fixed and
permeabilized with the Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD Biosci-
ences) according to the manufacturer’s instructions. Cells were stained for 50 min with antibodies
to IL-17A (TC11-18H10.1), IFN-γ (XMG1.2) and TNF-α (MP6-XT22). For the intracellular
staining of Granzyme B, cells were surface stained followed by fixation and permeabilization with
the Cytofix/Cytoperm Fixation/Permeabilization Solution Kit and staining with anti-Granzyme
B (QA16A02, Biolegend). For the intranuclear staining of transcription factors, cells were fixed
and permeablized with the Foxp3/Transcription Factor Staining Buffer Set (eBioscience) after
surface staining according to manufacturer’s instructions. Cells were stained for 50 min with anti-
bodies to FoxP3 (FJK-16s), RORγt (B2D) from Invitrogen and Tbet (4B10) (from Biolegend).
Samples were aquired on a LSRII Fortessa (BD Biosciences) and analyzed using Flowjo software.
Quantitative PCR
RNA was isolated from scraped gastric mucosa or from FACS-sorted cells using the RNeasy
Mini kit (QIAGEN) according to the manufacturer’s instructions. Complementary DNA
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synthesis was performed using Superscript III reverse transcriptase (QIAGEN). Quantitative
PCR reactions for the candidate genes were performed using TaqMan gene expression assays
(Csf2 Mm01290062_m1, Cxcl9 Mm00434946_m1, Cxcl10 Mm00445235_m1, Cxcl11 Mm004
44662_m1, Foxp3 Mm00475162_m1, Gzmb Mm00442837_m1, Hprt Mm03024075_m1, Ifng
Mm01168134_m1, Il2 Mm00434256_m1, Il4 Mm00445259_m1, Il10 Mm01288386_m1, Il12a
Mm00434169_m1, Il13 Mm00434204_m1, Il23 Mm00518984_m1, Tbx21 Mm00450960_m1,
Tnf Mm00443258_m1, Rorc Mm01261022_m1; Applied Biosystems). Complementary DNA
samples were analyzed in duplicate using a Light Cycler 480 detection system (Roche) and
gene expression levels for each sample were normalized to HPRT expression. Mean relative
gene expression was determined, and the differences were calculated using the 2ΔC(t) method.
Statistical analysis
Statistical analysis was performed with Prism 6.0 (GraphPad Software). The nonparametric
Mann-Whitney U test was used for all direct statistical comparisons between two groups.
Multiple group comparisons were performed by one-way ANOVA followed by Holm-Sidak’s
multiple comparisons correction. Differences were considered statistically significant when
p< 0.05. � indicates p<0.05, �� p<0.01, ��� p<0.001, ���� p<0.0001.
Ethics statement
All animal experimentation was reviewed and approved by the Zurich Cantonal Veterinary
Office, which is the relevant body regulating animal work at the University of Zurich (licences
ZH67/2012, ZH24/2013, ZH170/2014, ZH224/2014, ZH140/2017 and ZH212/2018) and
adheres to the rules and regulations of the Swiss National Veterinary Office.
Supporting information
S1 Fig. The gastric lamina propria of BATF3-/- mice is populated by normal numbers of
macrophages and CD11b+ DCs and DCs of various subsets produce chemokines that acti-
vate CXCR3. (A-C) BATF3-/- and WT mice were infected with H. pylori for one or four
months and their gastric LP leukocytes were analyzed by FACS. Absolute counts of CD11b+
DCs, CD103+ CD11b+ DCs and macrophages in the gastric lamina propria of WT and
BATF3-/- mice in the steady state and at one and four months p.i. with H. pylori, as determined
by multi-color flow cytometry, are shown in A. Absolute counts of IFN-γ+ IL-17- CD4+ T-cells
and of IL-17+ IFN-γ- CD4+ T-cells are shown in B. Absolute counts of Tbet+ and of RORγt+
CD4+ T-cells are shown in C. (D) Representative FACS plots of Ki67 staining vs. CD4 of LP
preparations of BATF3-/- and WT mice, corresponding to the summary plot shown in Fig 1E.
(E,F) BATF3-/- and WT mice were co-housed from birth onwards and infected with H. pylori
for one month; their gastric LP leukocytes were analyzed by FACS along with those prepared
from uninfected co-housed controls of both genotypes. H. pylori colonization is shown in E,
and absolute counts of IFN-γ+ IL-17- CD4+ T-cells, of IL-17+ IFN-γ- CD4+ T-cells and of
TNF-α+ CD4+ T-cells are shown in F. (G) DCs of the indicated subsets were flow cytometri-
cally sorted from LP preparations of H. pylori-infected (one month) and control mice, and
subjected to qRT-PCR analysis with primers specific for CXCL9, 10 and 11. Each dot repre-
sents pooled cells sorted from 2–3 mice.
(DOCX)
S2 Fig. BATF3-dependent DCs are required for Th1 but not Th17 or Th2 responses during
systemic bacterial infection. (A,B) BATF3-/- and WT mice were infected with M. bovis BCG.
At three weeks p.i., frequencies of liver IL-17+ CD4+ T-cells were quantified by intracellular
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cytokine staining (A) and the indicated transcripts were analyzed by qRT-PCR of total liver
RNA (B).
(DOCX)
S3 Fig. BATF3-/- mice fail to recruit activated CD4+ and CD8+ T-cells to the tumor micro-
environment but exhibit normal frequencies and activation of NK cells. (A-I) WT and
BATF3-/- mice were subcutaneously injected in both flanks with 5×105 MC38 cells. Tumors
were analyzed after 15 days with respect to the infiltration of various leukocyte populations, and
to gene expression. Absolute numbers per mg of tumor tissue of the two indicated DC popula-
tions are shown in A. Absolute numbers per mg of tumor tissue of CD4+ and CD8+ T-cells are
shown in B. The frequencies of intratumoral NK cells are shown in C. Absolute numbers per
mg of tumor tissue of cytokine-expressing CD4+ and CD8+ T-cells are shown in D and E, and
the activation of intratumoral NK cells, as assessed by CD69 staining is shown in F. (G) Gran-
zyme B expression by intratumoral CD8+ T-cells as assessed by intracellular cytokine staining
and granzyme B transcript levels as assessed by qRT-PCR of unsorted tumor tissue. (H) TNF-α
transcript levels as assessed by qRT-PCR of unsorted tumor tissue. In A-G, left panel, a repre-
sentative study of two independent ones is shown. In G, right panel and H, pooled data from
the two studies shown in Fig 3 are shown. (I) Gating strategy for the FACS-based quantification
of CXCL9-positive cells among CD11c+ DCs; the isotype control is shown on the left.
(DOCX)
S4 Fig. The recruitment of peripherally induced Tregs to infected tissues is impaired in
BATF3-/- mice. (A-H) BATF3-/- and WT mice were infected at six weeks of age with H.
pylori for one month and their gastric lamina propria Treg compartment was analyzed by
FACS relative to uninfected controls of both genotypes. Absolute counts per stomach are
shown for all Foxp3+ Tregs in A, for neuropilin-positive tTregs in B and for neuropilin-neg-
ative pTregs in C; D and E show absolute counts of Tbet+ pTregs and of Tbet+ RORγt+
pTregs. The expression of TIGIT, CD44 and TIM3 is shown in neuropilin-negative pTregs
in F-H. (I-M) BATF3-/- and WT mice were co-housed from birth, and infected at six weeks
of age with H. pylori for one month; their gastric lamina propria Treg compartment was
analyzed by FACS relative to uninfected controls of both genotypes. Absolute counts per
stomach are shown for the indicated Treg subsets in I-M. Horizontal lines indicate medians
throughout; p-values were calculated using one-way ANOVA followed by Holm-Sidak’s
multiple comparisons correction. Results in A-E are pooled from two independent studies;
data in F-H are from a representative study of the two shown in A-E, and the co-housing
study (I-M) was performed once.
(DOCX)
S5 Fig. MLN Treg populations in H. pylori-infected WT and BATF3-/- mice. (A-C)
BATF3-/- and WT mice were infected at six weeks of age with H. pylori for one month and
their MLN Treg compartment was analyzed by FACS relative to uninfected controls of
both genotypes. All MLNs were collected and stained for this purpose. Absolute counts in
all MLNs are shown for all Foxp3+ Tregs in A, for neuropilin-positive tTregs in B and for
neuropilin-negative pTregs in C. (D-F) BATF3-/- and WT mice were co-housed from
birth, but otherwise treated as described in A-C. The frequencies of the indicated Treg
populations are shown. Horizontal lines indicate medians throughout; p-values were cal-
culated using one-way ANOVA followed by Holm-Sidak’s multiple comparisons correc-
tion.
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